Semaglutid schützt Herz und Nieren bei Typ-2-Diabetes
Crossref DOI link: https://doi.org/10.1007/s15006-024-4438-6
Published Online: 2024-11-08
Published Print: 2024-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schwinger, Robert H. G.
Text and Data Mining valid from 2024-11-01
Version of Record valid from 2024-11-01
Article History
First Online: 8 November 2024